Related Experiment Video

Updated: Jan 20, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.4K

Toll-like receptors: The role in bladder cancer development, progression and immunotherapy

Solmaz Ohadian Moghadam1, Mohammad Reza Nowroozi1

  • 1Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Scandinavian Journal of Immunology
|August 27, 2019
PubMed

Insights

Toll-like receptors (TLRs) are crucial in bladder cancer immunity. Understanding TLR signaling pathways and using TLR agonists offers promising new immunotherapeutic strategies for bladder cancer treatment, potentially overcoming limitations of current therapies.

Area of Science:

  • Immunology
  • Oncology
  • Urology

Background:

  • Bladder cancer is a major global health concern with incompletely understood immune mechanisms.
  • Toll-like receptors (TLRs) are vital immune components expressed on both immune and tumor cells, influencing cancer progression and treatment.
  • Reduced TLR expression is observed in bladder tumors, particularly non-muscle-invasive types.

Purpose of the Study:

  • To review the mechanisms of Toll-like receptors (TLRs) in bladder cancer development.
  • To discuss the therapeutic applications of TLR agonists in bladder cancer treatment.
  • To explore alternative immunotherapeutic strategies for bladder cancer.

Main Methods:

  • Literature review of recent studies on TLRs and bladder cancer.
  • Analysis of TLR signaling pathways in cancer progression and immune response.
  • Evaluation of TLR agonists as potential immunotherapeutic agents.

Main Results:

  • TLRs play a significant role in the immune defense of the bladder urothelium.
  • TLR agonists demonstrate immunostimulatory effects and immunotherapeutic potential against cancer.
  • Bacillus Calmette-Guerin (BCG), a TLR2 and TLR4 agonist, is an established immunotherapy for bladder cancer, though associated with adverse effects.

Conclusions:

  • Understanding TLRs' role in bladder cancer is key to developing novel treatments.
  • TLR agonists represent a promising avenue for bladder cancer immunotherapy, especially for BCG non-responders.
  • Further research into TLR signaling pathways could revolutionize bladder cancer therapeutic strategies.
Keywords:
TLR agonistsToll-like receptorbladder cancerimmunotherapy

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.9K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Urinary Bladder01:23

Urinary Bladder

The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.2K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.6K